A federal judge has weeded out claims by Abbott Laboratories that hundreds of distributors and pharmacies are defrauding the pharmaceutical giant in the market for diabetes test strips.
U.S. District Judge Carol Bagley Amon of the Eastern District of New York dismissed racketeering and unjust enrichment claims against some 300 defendants accused of exploiting the difference in price between FreeStyle and FreeStyle Lite strips, depending on where they are sold. But she allowed trademark, fraud and importation claims to remain.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
